The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy

Friday, April 5, 3:00pm - 4:00pm (EDT)

Time shown in-05:00 America, New York

Mark your calendars for Friday, April 5, from 12:00 p.m. to 1:00 p.m., as Harvard professor and immunologist, Jennifer Guerriero, PhD, discusses "The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy."

Dr. Guerriero is a PhD immunologist and runs an independent laboratory at Brigham and Women’s Hospital (BWH) / Harvard Cancer Center (HCC) that focuses on developing novel strategies to modulate tumor associated macrophages (TAMs). The Guerriero laboratory works on unraveling the complexity of TAM biology, ontogeny and metabolic regulation with the goal of developing clinically effective strategies to target TAMs to promote T-cell activation and weaken the immune-suppressive TME to improve immunotherapy response rates.

Please fill out the information below to register for the event.

Goingdone
Interestedstar_border
Can't goclear

Name

Attending

Confirmed.

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Add to Calendar 2024/04/05 12:00:00 2024/04/05 13:00:00 America/Los_Angeles The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy Mark your calendars for Friday, April 5, from 12:00 p.m. to 1:00 p.m., as Harvard professor and immunologist, Jennifer Guerriero, PhD, discusses "The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy."

Dr. Guerriero is a PhD immunologist and runs an independent laboratory at Brigham and Women’s Hospital (BWH) / Harvard Cancer Center (HCC) that focuses on developing novel strategies to modulate tumor associated macrophages (TAMs). The Guerriero laboratory works on unraveling the complexity of TAM biology, ontogeny and metabolic regulation with the goal of developing clinically effective strategies to target TAMs to promote T-cell activation and weaken the immune-suppressive TME to improve immunotherapy response rates. Goldberg Auditorium / https://uchealth.zoom.us/j/84019295577 false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689

Confirmed.

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Thank you!

Your changes have been saved. Thanks for keeping us updated.

Goldberg Auditorium / https://uchealth.zoom.us/j/84019295577

Jennifer Guerriero, PhD

Link: